Photocrosslinkable chitosan modified with angiopoietin-1 peptide, QHREDGS, promotes survival of neonatal rat heart cells

Journal of Biomedical Materials Research - Part A

Volumn 95, Issue 1, 2010, Pages 105-117

  Rask, Fiona ^a   Dallabrida, Susan M ^b   Ismail, Nesreen S ^b   Amoozgar, Zohreh ^c   Yeo, Yoon ^c,d   Rupnick, Maria A ^b,e   Radisic, Milica ^a,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c PURDUE UNIVERSITY   (United States)

^d PURDUE UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Angiopoietin 1; Cardiomyocyte; Chitosan; Peptide; UV polymerization

Indexed keywords

ANGIOPOIETINS; APOPTOSIS; BONE MARROW CELLS; CARDIOMYOCYTES; CASPASES; CELL LOSS; CELL SURVIVAL; CURRENT CELLS; GLASS SLIDES; GLASS SUBSTRATES; INTEGRIN BINDING; MODIFIED CHITOSAN; MYOCARDIAL INFARCTION; MYOCYTES; NEONATAL RAT; SCAR FORMATION; THIN LAYERS; TROPONIN I; UV LIGHT; UV POLYMERIZATION;

CELL DEATH; CHITIN; CHITOSAN; HEART; LIGHT CONTROL GLASS; PEDIATRICS; PEPTIDES; POLYMERIZATION; POPULATION STATISTICS; SPIN GLASS; SUBSTRATES; ACIDS;

HYDROGELS;

ANGIOPOIETIN 1; AZIDOBENZOIC ACID; BENZOIC ACID; CASPASE 3; CASPASE 7; CHITOSAN; INTEGRIN; PACLITAXEL; QHREDGS PROTEIN; TROPONIN I; UNCLASSIFIED DRUG; 4 AZIDOBENZOIC ACID; 4-AZIDOBENZOIC ACID; AZIDE; CROSS LINKING REAGENT; PEPTIDE; BENZOIC ACID DERIVATIVE; GLUTAMINYLHISTIDYLARGINYLGLUTAMYLASPARTYLGLYCYL SERINE;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ADHESION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; HEART MUSCLE CELL; HYDROGEL; IMMUNOHISTOCHEMISTRY; NEWBORN; NONHUMAN; PHOTOCROSSLINKING; RAT; ULTRAVIOLET RADIATION; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; HEART MUSCLE; METABOLISM; MOLECULAR GENETICS; SCANNING ELECTRON MICROSCOPY; SPRAGUE DAWLEY RAT; SURFACE PROPERTY; ANIMAL CELL; CHEMICAL MODIFICATION; DRUG CONJUGATION; ENZYME ACTIVATION; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANGIOPOIETIN-1; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; AZIDES; CELL ADHESION; CELL SURVIVAL; CELLS, CULTURED; CHITOSAN; CROSS-LINKING REAGENTS; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR SEQUENCE DATA; MYOCARDIUM; MYOCYTES, CARDIAC; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SURFACE PROPERTIES; TROPONIN I; ULTRAVIOLET RAYS;

EID: 77956482606     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32808     Document Type: Article

References (94)

1. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res 1998;83:15-26.
2. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005;23:845-856.
3. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: The scientific foundations of cardiac repair. J Clin Invest 2005;115:572-583. (Pubitemid 40322227)
4. Muller-Ehmsen J, Peterson KL, Kedes L, Whittaker P, Dow JS, Long TI, Laird PW, Kloner RA. Rebuilding a damaged heart: Long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation 2002;105:1720-1726.
5. Reinecke H, Zhang M, Bartosek T, Murry CE. Survival, integration, and differentiation of cardiomyocyte grafts: A study in normal and injured rat hearts. Circulation 1999;100:193-202.
6. Huwer H, Winning J, Vollmar B, Welter C, Lohbach C, Menger MD, Schafers HJ. Long-term cell survival and hemodynamic improvements after neonatal cardiomyocyte and satellite cell transplantation into healed myocardial cryoinfarcted lesions in rats. Cell Transplant 2003;12:757-767.
7. Li RK, Jia ZQ, Weisel RD, Mickle DA, Zhang J, Mohabeer MK, Rao V, Ivanov J. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 1996;62:654-660; discussion 660-661.
8. Soonpaa MH, Koh GY, Klug MG, Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994;264:98-101.
9. Muller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, Long TI, Laird PW, Kedes L. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 2002;34:107-116. (Pubitemid 35229976)
10. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: Graft cell death and antideath strategies. J Mol Cell Cardiol 2001;33:907-921.
11. Reffelmann T, Kloner RA. Cellular cardiomyoplasty-cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res 2003;58:358-368.
12. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature hematopoietic fates in ischaemic myocardium. Nature 2004;428:668-673.
13. Kofidis T, Lebl DR, Martinez EC, Hoyt G, Tanaka M, Robbins RC. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 2005;112(9 Suppl):I173-I177. (Pubitemid 41266670)
14. Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng 2004;10:403-409.
15. Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 2004;44:654-660. (Pubitemid 39089073)
16. Ryu JH, Kim IK, Cho SW, Cho MC, Hwang KK, Piao H, Piao S, Lim SH, Hong YS, Choi CY, Yoo KJ, Kim BS. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 2005;26:319-326.
17. Laflamme MA, Gold J, Xu C, Hassanipour M, Rosler E, Police S, Muskheli V, Murry CE. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 2005;167:663-671.
18. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007;25:1015-1024.
19. Davis ME, Motion JP, Narmoneva DA, Takahashi T, Hakuno D, Kamm RD, Zhang S, Lee RT. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005;111:442-450. (Pubitemid 40204428)
20. Davis ME, Hsieh PC, Takahashi T, Song Q, Zhang S, Kamm RD, Grodzinsky AJ, Anversa P, Lee RT. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci USA 2006;103:8155-8160.
21. Shapira-Schweitzer K, Habib M, Gepstein L, Seliktar D. A photo-polymerizable hydrogel for 3D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells. J Mol Cell Cardiol 2009;46:213-224.
22. Fujimoto KL, Ma Z, Nelson DM, Hashizume R, Guan J, Tobita K, Wagner WR. Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. Biomaterials 2009;30:4357-4368.
23. Dobner S, Bezuidenhout D, Govender P, Zilla P, Davies N. A synthetic nondegradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling. J Card Fail 2009;15:629-636.
24. Landa N, Miller L, Feinberg MS, Holbova R, Shachar M, Freeman I, Cohen S, Leor J. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008;117:1388-1396.
25. Leor J, Tuvia S, Guetta V, Manczur F, Castel D, Willenz U, Petnehazy O, Landa N, Feinberg MS, Konen E, Goitein O, Tsur-Gang O, Shaul M, Klapper L, Cohen S. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J Am Coll Cardiol 2009;54:1014-1023.
26. Wall ST, Walker JC, Healy KE, Ratcliffe MB, Guccione JM. Theoretical impact of the injection of material into the myocardium: A finite element model simulation. Circulation 2006;114:2627-2635.
27. Siddiqui AJ, Blomberg P, Wardell E, Hellgren I, Eskandarpour M, Islam KB, Sylven C. Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium. Biochem Biophys Res Commun 2003;310:1002-1009. (Pubitemid 37188722)
28. Zhou L, Ma W, Yang Z, Zhang F, Lu L, Ding Z, Ding B, Ha T, Gao X, Li C. VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways. Gene Ther 2005;12:196-202.
29. Dallabrida SM, Ismail N, Oberle JR, Himes BE, Rupnick MA. Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circ Res 2005;96:e8-e24.
30. Dallabrida SM, Ismail NS, Pravda EA, Parodi EM, Dickie R, Durand EM, Lai J, Cassiola F, Rogers RA, Rupnick MA. Integrin binding angiopoietin-1 monomers reduce cardiac hypertrophy. FASEB J 2008;22:3010-3023.
31. Risbud M, Bhonde M, Bhonde R. Chitosan-polyvinyl pyrrolidone hydrogel does not activate macrophages: Potentials for transplantation applications. Cell Transplant 2001;10:195-202.
32. Prasitsilp M, Jenwithisuk R, Kongsuwan K, Damrongchai N, Watts P. Cellular responses to chitosan in vitro: The importance of deacetylation. J Mater Sci Mater Med 2000;11:773-778. (Pubitemid 32014530)
33. Muzzarelli RAA. Biochemical significance of exogenous chitins and chitosans in animals and patients. Carbohydr Polym 1993;20:7-16.
34. Obara K, Ishihara M, Ishizuka T, Fujita M, Ozeki Y, Maehara T, Kikuchi M, Kurita A. Photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 stimulates wound healing in healing-impaired db/db mice. Biomaterials 2003;24:3437-3444.
35. Ishihara M, Nakanishi K, Ono K, Sato M, Kikuchi M, Saito Y, Yura H, Matsui T, Hattori H, Uenoyama M, Kurita A. Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials 2002;23:833-840. (Pubitemid 33108958)
36. Ono K, Ishihara M, Ozeki Y, Deguchi H, Sato M, Saito Y, Yura H, Sato M, Kikuchi M, Kurita A, Maehara T. Experimental evaluation of photocrosslinkable chitosan as a biologic adhesive with surgical applications. Surgery 2001;130:844-850.
37. Kawashima Y, Yamamoto H, Takeuchi H, Kuno Y. Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm Dev Technol 2000;5:77-85. (Pubitemid 30069202)
38. Bowman K, Leong KW. Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomed 2006;1:117-128.
39. Roy K, Mao H-Q, Huang S-K, Leong KW. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999;5:387-391.
40. van der Merwe SM, Verhoef JC, Verheijden JHM, Kotzé AF, Junginger HE. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm 2004;58:225-235.
41. VandeVord PJ, Matthew HWT, DeSilva SP, Mayton L, Wu B, Wooley PH. Evaluation of the biocompatibility of a chitosan scaffold in mice. J Biomed Mater Res 2002;59:585-590.
42. Nettles DL, Elder SH, Gilbert JA. Potential use of chitosan as a cell scaffold material for cartilage tissue engineering. Tissue Eng 2002;8:1009-1016.
43. Yeo Y, Geng W, Ito T, Kohane DS, Burdick JA, Radisic M. Photocrosslinkable hydrogel for myocyte cell culture and injection. J Biomed Mater Res B Appl Biomater 2007;81:312-322. (Pubitemid 46685097)
44. Graber ML, DiLillo DC, Friedman BL, Pastoriza-Munoz E. Characteristics of fluoroprobes for measuring intracellular pH. Anal Biochem 1986;156:202-212.
45. Radisic M, Park H, Shing H, Consi T, Schoen FJ, Langer R, Freed LE, Vunjak-Novakovic G. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci USA 2004;101:18129-18134. (Pubitemid 40054085)
46. Karp JM, Yeo Y, Geng W, Cannizarro C, Yan K, Kohane DS, Vunjak-Novakovic G, Langer RS, Radisic M. A photolithographic method to create cellular micropatterns. Biomaterials 2006;27:4755-4764.
47. Iyer RK, Chiu LL, Radisic M. Microfabricated poly(ethylene glycol) templates enable rapid screening of triculture conditions for cardiac tissue engineering. J Biomed Mater Res A 2009;89:616-631.
48. Saji K, Fukumoto Y, Suzuki J, Fukui S, Nawata J, Shimokawa H. Colchicine, a microtubule depolymerizing agent, inhibits myocardial apoptosis in rats. Tohoku J Exp Med 2007;213:139-148.
49. Nicholson DW, Thornberry NA. Caspases: Killer proteases. Trends Biochem Sci 1997;22:299-306.
50. Boateng SY, Lateef SS, Mosley W, Hartman TJ, Hanley L, Russell B. RGD and YIGSR synthetic peptides facilitate cellular adhesion identical to that of laminin and fibronectin but alter the physiology of neonatal cardiac myocytes. Am J Physiol Cell Physiol 2005;288:C30-C38.
51. Anversa P, Cheng W, Liu Y, Leri A, Redaelli G, Kajstura J. Apoptosis and myocardial infarction. Basic Res Cardiol 1998;93(Suppl 3):8-12.
52. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Apoptosis in relevant clinical situations: Contribution of apoptosis in myocardial infarction. Cardiovasc Res 2000;45:630-641. (Pubitemid 30047129)
53. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, Gambert SR, Cigola E, Anversa P. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996;28:2005-2016.
54. Ono K, Ishihara M, Ozeki Y, Deguchi H, Sato M, Saito Y, Yura H, Kikuchi M, Kurita A, Maehara T. Experimental evaluation of photocrosslinkable chitosan as a biologic adhesive with surgical applications. Surgery 2001;130:844-850.
55. Ishihara M, Nakanishi K, Ono K, Sato M, Kikuchi M, Saito Y, Yura H, Matsui T, Hattori H, Uenoyama M, Kurita A. Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials 2002;23:833-840. (Pubitemid 33108958)
56. Ishihara M, Obara K, Ishizuka T, Fujita M, Sato M, Masuoka K, Saito Y, Yura H, Matsui T, Hattori H, Kikuchi M, Kurita A. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J Biomed Mater Res A 2003;64:551-559.
57. Fujita M, Kinoshita M, Ishihara M, Kanatani Y, Morimoto Y, Simizu M, Ishizuka T, Saito Y, Yura H, Matsui T, Takase B, Hattori H, Kikuchi M, Maehara T. Inhibition of vascular prosthetic graft infection using a photocrosslinkable chitosan hydrogel. J Surg Res 2004;121:135-140.
58. Kendra DF, Hadwiger LA. Characterization of the smallest chitosan oligomer that is maximally antifungal to Fusarium solani and elicits pisatin formation in Pisum sativum. Exp Mycol 1984;8:276-281.
59. No HK, Park NY, Lee SH, Meyers SP. Antibacterial activity of chitosans and chitosan oligomers with different molecular weights. Int J Food Microbiol 2002;74:65-72.
60. Sudarshan NR, Hoover DG. Antibacterial action of chitosan. Food Biotech 1992;6:257-272.
61. Fujita M, Kinoshita M, Ishihara M, Kanatani Y, Morimoto Y, Simizu M, Ishizuka T, Saito Y, Yura H, Matsui T, Takase B, Hattori H, Kikuchi M, Maehara T. Inhibition of vascular prosthetic graft infection using a photocrosslinkable chitosan hydrogel. J Surg Res 2004;121:135-140.
62. Gonzalez AL, Gobin AS, West JL, McIntire LV, Smith CW. Integrin interactions with immobilized peptides in polyethylene glycol diacrylate hydrogels. Tissue Eng 2004;10:1775-1786.
63. Gobin AS, West JL. Val-ala-pro-gly, an elastin-derived nonintegrin ligand: smooth muscle cell adhesion and specificity. J Biomed Mater Res A 2003;67:255-259.
64. Ho MH, Wang DM, Hsieh HJ, Liu HC, Hsien TY, Lai JY, Hou LT. Preparation and characterization of RGD-immobilized chitosan scaffolds. Biomaterials 2005;26:3197-3206. (Pubitemid 39647254)
65. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau JP, Duboc D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-1083.
66. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belem L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294-2302.
67. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomized controlled clinical trial. Lancet 2004;364:141-148.
68. Shapira-Schweitzer K, Seliktar D. Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial. Acta Biomater 2007;3:33-41. (Pubitemid 44804303)
69. Radisic M, Malda J, Epping E, Geng W, Langer R, Vunjak-Novakovic G. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng 2006;93:332-343.
70. Ishihara M, Obara K, Ishizuka T, Fujita M, Sato M, Masuoka K, Saito Y, Yura H, Matsui T, Hattori H, Kikuchi M, Kurita A. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J Biomed Mater Res A 2003;64:551-559.
71. Chiang KC, Chowdhury MF, Iyer RK, Stanford WL, Radisic M. Engineering surfaces for site specific vascular differentiation of mouse embryonic stem cells. Acta Biomaterialia 2010;6:1904-1916.
72. Erhardt JA, Ohlstein EH, Toomey JR, Gabriel MA, Willette RN, Yue TL, Barone FC, Parsons AA. Activation of caspase-3/caspase-3-like activity in rat cardiomyocytes by an RGD peptide, but not the GPIIb/IIIa antagonist lotrafiban. Thromb Res 2001;103:143-148.
73. Sarin V, Gaffin RD, Meininger GA, Muthuchamy M. Arginine-glycine-aspartic acid (RGD)-containing peptides inhibit the force production of mouse papillary muscle bundles via alpha 5 beta 1 integrin. J Physiol 2005;564(Part 2):603-617.
74. Balasubramanian S, Kuppuswamy D. RGD-containing peptides activate S6K1 through beta3 integrin in adult cardiac muscle cells. J Biol Chem 2003;278:42214-42224.
75. Grinnell F, Feld MK. Initial adhesion of human fibroblasts in serum-free medium: Possible role of secreted fibronectin. Cell 1979;17:117-129. (Pubitemid 9188216)
76. Culp LA, Buniel JF. Substrate-attached serum and cell proteins in adhesion of mouse fibroblasts. J Cell Physiol 1976;88:89-106.
77. Peyton SR, Raub CB, Keschrumrus VP, Putnam AJ. The use of poly(ethylene glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth muscle cells. Biomaterials 2006;27:4881-4893.
78. Drury JL, Mooney DJ. Hydrogels for tissue engineering: Scaffold design variables and applications. Biomaterials 2003;24:4337-4351.
79. Pelham RJ Jr, Wang Y. Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc Natl Acad Sci USA 1997;94:13661-13665.
80. Jacot JG, McCulloch AD, Omens JH. Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. Biophys J 2008;95:3479-3487.
81. Engler AJ, Carag-Krieger C, Johnson CP, Raab M, Tang HY, Speicher DW, Sanger JW, Sanger JM, Discher DE. Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: Scarlike rigidity inhibits beating. J Cell Sci 2008;121(Part 22):3794-3802.
82. Bhana B, Iyer RK, Chen WLK, Zhao R, Sider KL, Likhitpanichkul M, Simmons CA, Radisic M. Influence of substrate stiffness on the phenotype of heart cells. Biotechnol Bioeng 2010;105:1148-1160.
83. Engler AJ, Richert L, Wong JY, Picart C, Discher DE. Surface probe measurements of the elasticity of sectioned tissue, thin gels and polyelectrolyte multilayer films: Correlations between substrate stiffness and cell adhesion. Surf Sci 2004;570:142-154.
84. Radisic M, Park H, Martens TP, Salazar-Lazaro JE, Geng W, Wang Y, Langer R, Freed LE, Vunjak-Novakovic G. Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. J Biomed Mater Res A 2008;86:713-724.
85. Engelmayr GC Jr, Cheng M, Bettinger CJ, Borenstein JT, Langer R, Freed LE. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater 2008;7:1003-1010.
86. Naito H, Melnychenko I, Didie M, Schneiderbanger K, Schubert P, Rosenkranz S, Eschenhagen T, Zimmermann WH. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 2006;114(1 Suppl):I72-I78.
87. Nag AC. Study of nonmuscle cells of the adult mammalian heart: A fine structural analysis and distribution. Cytobios 1980;28:41-61.
88. Sussman MA, McCulloch A, Borg TK. Dance band on the titanic: Biomechanical signaling in cardiac hypertrophy. Circ Res 2002;91:888-898. (Pubitemid 35373588)
89. Gaudesius G, Miragoli M, Thomas SP, Rohr S. Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ Res 2003;93:421-428.
90. Rudy Y. Conductive bridges in cardiac tissue: A beneficial role or an arrhythmogenic substrate? Circ Res 2004;94:709-711.
91. Camelliti P, Borg TK, Kohl P. Structural and functional characterization of cardiac fibroblasts. Cardiovasc Res 2005;65:40-51.
92. Kohl P. Heterogeneous cell coupling in the heart: An electrophysiological role for fibroblasts. Circ Res 2003;93:381-383.
93. Naito H, Melnychenko I, Didie M, Schneiderbanger K, Schubert P, Rosenkranz S, Eschenhagen T, Zimmermann WH. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 2006;114:I72-I78.
94. Brown M, Iyer R, Radisic M. Pulsatile perfusion bioreactor for cardiac tissue engineering. Biotechnol Progr 2008;24:907-920.